[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Donepezil.]
[L04AA27, fingolimod, Donepezil may increase the bradycardic activities of Fingolimod.]
[M03AB01, succinylcholine, The metabolism of Succinylcholine can be decreased when combined with Donepezil.]
[J01EC02, sulfadiazine, The metabolism of Donepezil can be decreased when combined with Sulfadiazine.]
[S01AB01, sulfamethizole, The metabolism of Donepezil can be decreased when combined with Sulfamethizole.]
[J01EC01, sulfamethoxazole, The metabolism of Donepezil can be decreased when combined with Sulfamethoxazole.]
[J01EC03, sulfamoxole, The metabolism of Donepezil can be decreased when combined with Sulfamoxole.]
[J01EB04, sulfapyridine, The metabolism of Donepezil can be decreased when combined with Sulfapyridine.]
[M04AB02, sulfinpyrazone, The metabolism of Donepezil can be decreased when combined with Sulfinpyrazone.]
[S01AB02, sulfisoxazole, The metabolism of Donepezil can be decreased when combined with Sulfisoxazole.]
[N05AL01, sulpiride, The risk or severity of adverse effects can be increased when Sulpiride is combined with Donepezil.]
[N03AX03, sulthiame, The risk or severity of adverse effects can be increased when Donepezil is combined with Sulthiame.]
[A10BB04, glibornuride, The metabolism of Glibornuride can be decreased when combined with Donepezil.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Donepezil.]
[N05CD07, temazepam, The risk or severity of adverse effects can be increased when Temazepam is combined with Donepezil.]
[L01CB02, teniposide, The metabolism of Donepezil can be decreased when combined with Teniposide.]
[G03BA03, testosterone, The metabolism of Donepezil can be decreased when combined with Testosterone.]
[N07XX06, tetrabenazine, The metabolism of Tetrabenazine can be decreased when combined with Donepezil.]
[S01HA03, tetracaine, The risk or severity of adverse effects can be increased when Donepezil is combined with Tetracaine.]
[N05AE05, lurasidone, The risk or severity of adverse effects can be increased when Donepezil is combined with Lurasidone.]
[A04AD10, dronabinol, Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Donepezil.]
[N04BC07, apomorphine, The risk or severity of adverse effects can be increased when Apomorphine is combined with Donepezil.]
[L04AX02, thalidomide, Donepezil may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Donepezil.]
[R06AD03, thiethylperazine, The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Donepezil.]
[N05CA19, thiopental, The therapeutic efficacy of Thiopental can be decreased when used in combination with Donepezil.]
[N05AB08, thioproperazine, The risk or severity of adverse effects can be increased when Donepezil is combined with Thioproperazine.]
[N05AC02, thioridazine, The metabolism of Donepezil can be decreased when combined with Thioridazine.]
[N05AF04, thiothixene, The risk or severity of adverse effects can be increased when Donepezil is combined with Thiothixene.]
[C01BB04, aprindine, The metabolism of Aprindine can be decreased when combined with Donepezil.]
[G04BE06, moxisylyte, Donepezil may increase the neuromuscular blocking activities of Moxisylyte.]
[N05AL03, tiapride, The risk or severity of adverse effects can be increased when Donepezil is combined with Tiapride.]
[B01AC05, ticlopidine, The metabolism of Donepezil can be decreased when combined with Ticlopidine.]
[N02AX01, tilidine, The risk or severity of adverse effects can be increased when Donepezil is combined with Tilidine.]
[S01ED01, timolol, Donepezil may increase the bradycardic activities of Timolol.]
[A10BB05, tolazamide, The metabolism of Donepezil can be decreased when combined with Tolazamide.]
[V04CA01, tolbutamide, The metabolism of Tolbutamide can be decreased when combined with Donepezil.]
[M03BX04, tolperisone, The risk or severity of adverse effects can be increased when Donepezil is combined with Tolperisone.]
[N02AX02, tramadol, The therapeutic efficacy of Tramadol can be decreased when used in combination with Donepezil.]
[N06AF04, tranylcypromine, The metabolism of Donepezil can be decreased when combined with Tranylcypromine.]
[N06AX05, trazodone, The risk or severity of adverse effects can be increased when Donepezil is combined with Trazodone.]
[L01XF01, tretinoin, The metabolism of Donepezil can be decreased when combined with Tretinoin.]
[S01BA05, triamcinolone, The therapeutic efficacy of Donepezil can be decreased when used in combination with Triamcinolone.]
[N05CD05, triazolam, The risk or severity of adverse effects can be increased when Donepezil is combined with Triazolam.]
[A03AB12, mepenzolate, The therapeutic efficacy of Mepenzolate can be decreased when used in combination with Donepezil.]
[N05AB06, trifluoperazine, The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Donepezil.]
[N05AD02, trifluperidol, The risk or severity of adverse effects can be increased when Donepezil is combined with Trifluperidol.]
[N05AA05, triflupromazine, The therapeutic efficacy of Triflupromazine can be decreased when used in combination with Donepezil.]
[D07AC02, fluclorolone, The therapeutic efficacy of Donepezil can be decreased when used in combination with Fluclorolone.]
[N04AA01, trihexyphenidyl, The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Donepezil.]
[R03BA07, mometasone, The therapeutic efficacy of Donepezil can be decreased when used in combination with Mometasone.]
[A03AA05, trimebutine, The therapeutic efficacy of Trimebutine can be decreased when used in combination with Donepezil.]
[R06AD01, trimeprazine, The risk or severity of adverse effects can be increased when Donepezil is combined with Alimemazine.]
[N03AC02, trimethadione, The risk or severity of adverse effects can be increased when Trimethadione is combined with Donepezil.]
[C02BA01, trimethaphan, The therapeutic efficacy of Trimethaphan can be decreased when used in combination with Donepezil.]
[J01EA01, trimethoprim, The metabolism of Donepezil can be decreased when combined with Trimethoprim.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Donepezil.]
[R06AC04, tripelennamine, The metabolism of Donepezil can be decreased when combined with Tripelennamine.]
[R06AX07, triprolidine, The risk or severity of adverse effects can be increased when Triprolidine is combined with Donepezil.]
[A03BB01, butylscopolamine, The therapeutic efficacy of Butylscopolamine can be decreased when used in combination with Donepezil.]
[J01FA08, troleandomycin, The metabolism of Donepezil can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The metabolism of Donepezil can be decreased when combined with Vilazodone.]
[S01FA06, tropicamide, The therapeutic efficacy of Tropicamide can be decreased when used in combination with Donepezil.]
[N06AX02, tryptophan, The risk or severity of adverse effects can be increased when Tryptophan is combined with Donepezil.]
[M03AA02, tubocurarine, The therapeutic efficacy of Tubocurarine can be decreased when used in combination with Donepezil.]
[L01EX04, vandetanib, Vandetanib may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[L02BX03, abiraterone, The metabolism of Donepezil can be decreased when combined with Abiraterone.]
[A10BH05, linagliptin, The metabolism of Donepezil can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Donepezil can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Donepezil can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, Rilpivirine may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[N03AX21, ezogabine, The risk or severity of adverse effects can be increased when Donepezil is combined with Ezogabine.]
[B01AC24, ticagrelor, The metabolism of Donepezil can be decreased when combined with Ticagrelor.]
[C08DA01, verapamil, The metabolism of Donepezil can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Donepezil can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Donepezil can be decreased when combined with Vinblastine.]
[B01AA03, warfarin, The metabolism of Donepezil can be increased when combined with Warfarin.]
[J05AF01, zidovudine, The metabolism of Donepezil can be decreased when combined with Zidovudine.]
[N05AF05, zuclopenthixol, The risk or severity of adverse effects can be increased when Donepezil is combined with Zuclopenthixol.]
[J05AE02, indinavir, The metabolism of Donepezil can be decreased when combined with Indinavir.]
[N03AX14, levetiracetam, The risk or severity of adverse effects can be increased when Donepezil is combined with Levetiracetam.]
[L01EC01, vemurafenib, Vemurafenib may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[L01ED01, crizotinib, Crizotinib may increase the bradycardic activities of Donepezil.]
[R03DC01, zafirlukast, The metabolism of Donepezil can be decreased when combined with Zafirlukast.]
[A02BC04, rabeprazole, Rabeprazole may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[N05AE04, ziprasidone, The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Donepezil.]
[N02BA01, aspirin, The metabolism of Acetylsalicylic acid can be decreased when combined with Donepezil.]
[L01EJ01, ruxolitinib, Ruxolitinib may increase the bradycardic activities of Donepezil.]
[G04BD07, tolterodine, The therapeutic efficacy of Tolterodine can be decreased when used in combination with Donepezil.]
[C07AB03, atenolol, Donepezil may increase the bradycardic activities of Atenolol.]
[J02AC03, voriconazole, The metabolism of Donepezil can be decreased when combined with Voriconazole.]
[M03AC04, atracurium, The therapeutic efficacy of Atracurium can be decreased when used in combination with Donepezil.]
[S01FA01, atropine, The therapeutic efficacy of Atropine can be decreased when used in combination with Donepezil.]
[L01XJ01, vismodegib, Vismodegib may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[H02AB11, prednylidene, The therapeutic efficacy of Donepezil can be decreased when used in combination with Prednylidene.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Donepezil.]
[M03BX01, baclofen, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Donepezil.]
[A08AA11, lorcaserin, The metabolism of Donepezil can be decreased when combined with Lorcaserin.]
[G04BD12, mirabegron, The serum concentration of Donepezil can be increased when it is combined with Mirabegron.]
[V03AX03, cobicistat, The metabolism of Donepezil can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Donepezil can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Donepezil can be decreased when it is combined with Enzalutamide.]
[L04AA31, teriflunomide, Teriflunomide may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[H02AA01, aldosterone, The therapeutic efficacy of Donepezil can be decreased when used in combination with Aldosterone.]
[L01EX05, regorafenib, Regorafenib may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[N05CA04, barbital, The therapeutic efficacy of Barbital can be decreased when used in combination with Donepezil.]
[J05AE04, nelfinavir, The metabolism of Donepezil can be decreased when combined with Nelfinavir.]
[S01GA07, brimonidine, Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Donepezil.]
[N04BD02, rasagiline, The risk or severity of adverse effects can be increased when Donepezil is combined with Rasagiline.]
[C08CA13, lercanidipine, Lercanidipine may increase the bradycardic activities of Donepezil.]
[A03FA09, mosapride, The risk or severity of adverse effects can be increased when Donepezil is combined with Mosapride.]
[S01AA13, fusidic acid, The metabolism of Donepezil can be decreased when combined with Fusidic acid.]
[N03AX22, perampanel, Perampanel may increase the central nervous system depressant (CNS depressant) activities of Donepezil.]
[L04AA29, tofacitinib, Donepezil may increase the bradycardic activities of Tofacitinib.]
[N02CC03, zolmitriptan, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Donepezil.]
[R06AC06, thonzylamine, The therapeutic efficacy of Thonzylamine can be decreased when used in combination with Donepezil.]
[G04BD10, darifenacin, The therapeutic efficacy of Darifenacin can be decreased when used in combination with Donepezil.]
[N01AA01, ethyl ether, The risk or severity of adverse effects can be increased when Donepezil is combined with Diethyl ether.]
[L01EX07, cabozantinib, The metabolism of Cabozantinib can be decreased when combined with Donepezil.]
[H01CB05, pasireotide, Donepezil may increase the bradycardic activities of Pasireotide.]
[G04BE03, sildenafil, The metabolism of Donepezil can be decreased when combined with Sildenafil.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Donepezil.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Donepezil.]
[C04AX11, bencyclane, Donepezil may increase the bradycardic activities of Bencyclane.]
[A10BH04, alogliptin, The metabolism of Alogliptin can be decreased when combined with Donepezil.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Donepezil can be decreased when combined with Glycerol phenylbutyrate.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the bradycardic activities of Donepezil.]
[L04AX06, pomalidomide, The risk or severity of adverse effects can be increased when Donepezil is combined with Pomalidomide.]
[G03XC05, ospemifene, The metabolism of Donepezil can be decreased when combined with Ospemifene.]
[N05AD07, benperidol, The risk or severity of adverse effects can be increased when Donepezil is combined with Benperidol.]
[M04AB03, benzbromarone, The metabolism of Donepezil can be decreased when combined with Benzbromarone.]
[A06AX06, tegaserod, The metabolism of Donepezil can be decreased when combined with Tegaserod.]
[R02AD01, benzocaine, The risk or severity of adverse effects can be increased when Donepezil is combined with Benzocaine.]
[M01AH01, celecoxib, The metabolism of Donepezil can be decreased when combined with Celecoxib.]
[N02CC02, naratriptan, The risk or severity of adverse effects can be increased when Donepezil is combined with Naratriptan.]
[L04AA18, everolimus, The metabolism of Donepezil can be decreased when combined with Everolimus.]
[N04AC01, benztropine, The therapeutic efficacy of Benzatropine can be decreased when used in combination with Donepezil.]
[L01EC02, dabrafenib, The serum concentration of Donepezil can be decreased when it is combined with Dabrafenib.]
[P03AX06, benzyl alcohol, The risk or severity of adverse effects can be increased when Donepezil is combined with Benzyl alcohol.]
[L01EB03, afatinib, Afatinib may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[N06AX28, levomilnacipran, The risk or severity of adverse effects can be increased when Donepezil is combined with Levomilnacipran.]
[C08EA02, bepridil, The metabolism of Donepezil can be decreased when combined with Bepridil.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Donepezil.]
[N06AX26, vortioxetine, The risk or severity of adverse effects can be increased when Donepezil is combined with Vortioxetine.]
[N03AF04, eslicarbazepine, The risk or severity of adverse effects can be increased when Donepezil is combined with Eslicarbazepine.]
[J05AP05, simeprevir, The metabolism of Donepezil can be decreased when combined with Simeprevir.]
[N03AG04, vigabatrin, The risk or severity of adverse effects can be increased when Donepezil is combined with Vigabatrin.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Donepezil.]
[C07AB04, acebutolol, Donepezil may increase the bradycardic activities of Acebutolol.]
[N05CH03, tasimelteon, The risk or severity of adverse effects can be increased when Donepezil is combined with Tasimelteon.]
[A16AA07, metreleptin, The metabolism of Donepezil can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Donepezil can be increased when combined with Apremilast.]
[S03BA03, betamethasone, The therapeutic efficacy of Donepezil can be decreased when used in combination with Betamethasone.]
[S01ED02, betaxolol, Donepezil may increase the bradycardic activities of Betaxolol.]
[L04AC11, siltuximab, The metabolism of Donepezil can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, Donepezil may increase the bradycardic activities of Ceritinib.]
[A03BA03, hyoscyamine, The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Donepezil.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be decreased when combined with Donepezil.]
[N01AX05, alfaxalone, The risk or severity of adverse effects can be increased when Donepezil is combined with Alfaxalone.]
[N07XX08, tafamidis, The serum concentration of Donepezil can be increased when it is combined with Tafamidis.]
[R03AC19, olodaterol, The metabolism of Olodaterol can be decreased when combined with Donepezil.]
[D11AA01, glycopyrronium, The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Donepezil.]
[N05CM19, suvorexant, Donepezil may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A16AX10, eliglustat, The metabolism of Donepezil can be decreased when combined with Eliglustat.]
[J01XA05, oritavancin, The metabolism of Donepezil can be decreased when combined with Oritavancin.]
[N05AA04, acepromazine, The risk or severity of adverse effects can be increased when Donepezil is combined with Acepromazine.]
[V04CX03, methacholine, The risk or severity of adverse effects can be increased when Donepezil is combined with Methacholine.]
[A06AH03, naloxegol, The risk or severity of respiratory depression can be increased when Naloxegol is combined with Donepezil.]
[N04AA02, biperiden, The therapeutic efficacy of Biperiden can be decreased when used in combination with Donepezil.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Donepezil.]
[J05AP09, dasabuvir, Dasabuvir may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[B01AA01, dicumarol, The metabolism of Donepezil can be decreased when combined with Dicoumarol.]
[N06AX11, mirtazapine, Donepezil may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Donepezil can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, Palbociclib may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[L01XH03, panobinostat, The metabolism of Donepezil can be decreased when combined with Panobinostat.]
[J05AP07, daclatasvir, Daclatasvir may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[N02BE01, acetaminophen, The metabolism of Donepezil can be decreased when combined with Acetaminophen.]
[A03AA09, difemerine, The therapeutic efficacy of Difemerine can be decreased when used in combination with Donepezil.]
[C01EB17, ivabradine, Donepezil may increase the bradycardic activities of Ivabradine.]
[J05AP06, asunaprevir, The metabolism of Donepezil can be decreased when combined with Asunaprevir.]
[A07DA06, eluxadoline, The risk or severity of respiratory depression can be increased when Eluxadoline is combined with Donepezil.]
[N05AX16, brexpiprazole, The risk or severity of adverse effects can be increased when Donepezil is combined with Brexpiprazole.]
[A04AD14, rolapitant, The metabolism of Donepezil can be decreased when combined with Rolapitant.]
[G02CX02, flibanserin, The risk or severity of adverse effects can be increased when Donepezil is combined with Flibanserin.]
[N05AX15, cariprazine, The risk or severity of adverse effects can be increased when Donepezil is combined with Cariprazine.]
[S01EC01, acetazolamide, The risk or severity of adverse effects can be increased when Acetazolamide is combined with Donepezil.]
[N05AB07, acetophenazine, The risk or severity of adverse effects can be increased when Donepezil is combined with Acetophenazine.]
[A02BC03, lansoprazole, Lansoprazole may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Donepezil.]
[J02AC05, isavuconazole, The metabolism of Donepezil can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, Osimertinib may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[L01ED03, alectinib, Alectinib may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[A10BB31, acetohexamide, The metabolism of Donepezil can be decreased when combined with Acetohexamide.]
[M04AB05, lesinurad, The metabolism of Lesinurad can be decreased when combined with Donepezil.]
[J05AP10, elbasvir, Elbasvir may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[J05AP11, grazoprevir, Grazoprevir may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[N05CA05, aprobarbital, The therapeutic efficacy of Aprobarbital can be decreased when used in combination with Donepezil.]
[N03AX23, brivaracetam, The risk or severity of adverse effects can be increased when Donepezil is combined with Brivaracetam.]
[L01XX52, venetoclax, The metabolism of Donepezil can be decreased when combined with Venetoclax.]
[N05BA08, bromazepam, The risk or severity of adverse effects can be increased when Donepezil is combined with Bromazepam.]
[N04BC01, bromocriptine, The risk or severity of adverse effects can be increased when Donepezil is combined with Bromocriptine.]
[A03AX08, alverine, The risk or severity of adverse effects can be increased when Donepezil is combined with Alverine.]
[R06AB01, brompheniramine, The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Donepezil.]
[N06AA19, amineptin, The risk or severity of adverse effects can be increased when Donepezil is combined with Amineptine.]
[C08CA01, amlodipine, Amlodipine may increase the bradycardic activities of Donepezil.]
[N06BX11, aniracetam, The risk or severity of adverse effects can be increased when Donepezil is combined with Aniracetam.]
[N01BB01, bupivacaine, The risk or severity of adverse effects can be increased when Bupivacaine is combined with Donepezil.]
[C07AA19, bupranolol, Donepezil may increase the bradycardic activities of Bupranolol.]
[N07BC01, buprenorphine, Donepezil may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[N05BE01, buspirone, The risk or severity of adverse effects can be increased when Buspirone is combined with Donepezil.]
[N06DA03, rivastigmine, Donepezil may increase the bradycardic activities of Rivastigmine.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Donepezil.]
[M02AA03, clofezone, Rabeprazole may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[N02AF01, butorphanol, The risk or severity of adverse effects can be increased when Butorphanol is combined with Donepezil.]
[S01GX07, azelastine, Donepezil may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[L01XK03, rucaparib, The metabolism of Donepezil can be decreased when combined with Rucaparib.]
[L01EF02, ribociclib, The metabolism of Donepezil can be decreased when combined with Ribociclib.]
[R03CC12, bambuterol, Donepezil may increase the neuromuscular blocking activities of Bambuterol.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Donepezil.]
[N02BF02, pregabalin, The therapeutic efficacy of Donepezil can be increased when used in combination with Pregabalin.]
[N03AX30, beclamide, The risk or severity of adverse effects can be increased when Donepezil is combined with Beclamide.]
[N06BC01, caffeine, Caffeine may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[S01HA02, benoxinate, Donepezil may increase the neuromuscular blocking activities of Oxybuprocaine.]
[R05DB01, benzonatate, Donepezil may increase the neuromuscular blocking activities of Benzonatate.]
[J05AE09, tipranavir, The metabolism of Donepezil can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Donepezil.]
[L04AB02, infliximab, The metabolism of Donepezil can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Donepezil can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, Brigatinib may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[N04BD03, safinamide, The risk or severity of adverse effects can be increased when Donepezil is combined with Safinamide.]
[N07AB02, bethanechol, The risk or severity of adverse effects can be increased when Donepezil is combined with Bethanechol.]
[J01MA23, delafloxacin, The metabolism of Donepezil can be increased when combined with Delafloxacin.]
[S01EB09, acetylcholine, The risk or severity of adverse effects can be increased when Donepezil is combined with Acetylcholine.]
[L01BC06, capecitabine, The metabolism of Donepezil can be decreased when combined with Capecitabine.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Donepezil.]
[L01EF03, abemaciclib, Abemaciclib may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[C07AB07, bisoprolol, Donepezil may increase the bradycardic activities of Bisoprolol.]
[J05AG03, efavirenz, The metabolism of Donepezil can be decreased when combined with Efavirenz.]
[C07AA17, bopindolol, Donepezil may increase the bradycardic activities of Bopindolol.]
[N04AA11, bornaprine, The therapeutic efficacy of Bornaprine can be decreased when used in combination with Donepezil.]
[N05AD06, bromperidol, The risk or severity of adverse effects can be increased when Donepezil is combined with Bromperidol.]
[N05CD09, brotizolam, The risk or severity of adverse effects can be increased when Donepezil is combined with Brotizolam.]
[R03BA02, budesonide, The therapeutic efficacy of Donepezil can be decreased when used in combination with Budesonide.]
[N05CA03, butobarbital, The therapeutic efficacy of Butobarbital can be decreased when used in combination with Donepezil.]
[J05AX18, letermovir, Letermovir may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[N06AA15, butriptyline, The risk or severity of adverse effects can be increased when Donepezil is combined with Butriptyline.]
[N05CA08, butylvinal, The risk or severity of adverse effects can be increased when Donepezil is combined with Vinylbital.]
[S01EB02, carbachol, The risk or severity of adverse effects can be increased when Donepezil is combined with Carbamoylcholine.]
[L02BB05, apalutamide, The metabolism of Donepezil can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Donepezil can be increased when combined with Carbamazepine.]
[A03AA03, camylofine, The therapeutic efficacy of Camylofin can be decreased when used in combination with Donepezil.]
[R06AA08, carbinoxamine, The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Donepezil.]
[C07AG02, carvedilol, Donepezil may increase the bradycardic activities of Carvedilol.]
[B02BX09, fostamatinib, Fostamatinib may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[N03AX24, cannabidiol, The risk or severity of adverse effects can be increased when Cannabidiol is combined with Donepezil.]
[B02BX08, avatrombopag, Avatrombopag may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[L01EC03, encorafenib, The metabolism of Encorafenib can be decreased when combined with Donepezil.]
[C07AB08, celiprolol, Donepezil may increase the bradycardic activities of Celiprolol.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Donepezil.]
[L01XX62, ivosidenib, The metabolism of Donepezil can be increased when combined with Ivosidenib.]
[P01BA07, tafenoquine, The metabolism of Tafenoquine can be decreased when combined with Donepezil.]
[N03AX17, stiripentol, The metabolism of Donepezil can be decreased when combined with Stiripentol.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Donepezil.]
[S01GX12, cetirizine, The risk or severity of adverse effects can be increased when Cetirizine is combined with Donepezil.]
[N05CM04, carbromal, The risk or severity of adverse effects can be increased when Donepezil is combined with Carbromal.]
[A10BB06, carbutamide, The metabolism of Carbutamide can be decreased when combined with Donepezil.]
[N01BA04, chloroprocaine, Donepezil may increase the neuromuscular blocking activities of Chloroprocaine.]
[R06AA06, chlorphenoxamine, The therapeutic efficacy of Chlorphenoxamine can be decreased when used in combination with Donepezil.]
[M01AC05, lornoxicam, The metabolism of Lornoxicam can be decreased when combined with Donepezil.]
[M03BA02, carisoprodol, The risk or severity of adverse effects can be increased when Carisoprodol is combined with Donepezil.]
[R03BB08, revefenacin, The therapeutic efficacy of Revefenacin can be decreased when used in combination with Donepezil.]
[L04AA39, emapalumab, The metabolism of Donepezil can be increased when combined with Emapalumab.]
[L01EX13, gilteritinib, Gilteritinib may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[L01XJ03, glasdegib, Glasdegib may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[N07XX05, amifampridine, The risk or severity of adverse effects can be increased when Donepezil is combined with Amifampridine.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Donepezil.]
[A03FA08, cinitapride, The risk or severity of adverse effects can be increased when Donepezil is combined with Cinitapride.]
[P02BX04, triclabendazole, The metabolism of Donepezil can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The risk or severity of adverse effects can be increased when Donepezil is combined with Esketamine.]
[L04AA42, siponimod, The metabolism of Siponimod can be decreased when combined with Donepezil.]
[J01FA09, clarithromycin, The metabolism of Donepezil can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, The risk or severity of adverse effects can be increased when Donepezil is combined with Solriamfetol.]
[N06AX29, brexanolone, The risk or severity of adverse effects can be increased when Donepezil is combined with Brexanolone.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Donepezil.]
[N05BA09, clobazam, The metabolism of Donepezil can be decreased when combined with Clobazam.]
[H02AB14, cloprednol, The therapeutic efficacy of Donepezil can be decreased when used in combination with Cloprednol.]
[N05BA22, cloxazolam, The risk or severity of adverse effects can be increased when Donepezil is combined with Cloxazolam.]
[C09CA06, candesartan, The metabolism of Donepezil can be decreased when combined with Candesartan.]
[L04AB01, etanercept, The metabolism of Donepezil can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The therapeutic efficacy of Donepezil can be decreased when used in combination with Cortivazol.]
[L01EM03, alpelisib, The serum concentration of Donepezil can be decreased when it is combined with Alpelisib.]
[L02BB06, darolutamide, The serum concentration of Donepezil can be increased when it is combined with Darolutamide.]
[N05AA06, cyamemazine, The risk or severity of adverse effects can be increased when Donepezil is combined with Cyamemazine.]
[M03BX08, cyclobenzaprine, The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Donepezil.]
[L01EJ02, fedratinib, Fedratinib may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[N07XX11, pitolisant, The serum concentration of Donepezil can be decreased when it is combined with Pitolisant.]
[N04CX01, istradefylline, Istradefylline may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[G04BE04, yohimbine, The risk or severity of adverse effects can be increased when Donepezil is combined with Yohimbine.]
[H02AB13, deflazacort, The therapeutic efficacy of Donepezil can be decreased when used in combination with Deflazacort.]
[N02CC08, lasmiditan, The serum concentration of Donepezil can be increased when it is combined with Lasmiditan.]
[G03AC09, desogestrel, The metabolism of Donepezil can be decreased when combined with Desogestrel.]
[B06AX03, voxelotor, The metabolism of Voxelotor can be decreased when combined with Donepezil.]
[N03AX25, cenobamate, The serum concentration of Donepezil can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, The serum concentration of Donepezil can be increased when it is combined with Givosiran.]
[R06AB06, dexbrompheniramine, The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Donepezil.]
[R06AB02, dexchlorpheniramine, The metabolism of Donepezil can be decreased when combined with Dexchlorpheniramine.]
[N02AX03, dezocine, The risk or severity of adverse effects can be increased when Donepezil is combined with Dezocine.]
[L01EX18, avapritinib, The metabolism of Donepezil can be decreased when combined with Avapritinib.]
[N05CM21, lemborexant, The risk or severity of adverse effects can be increased when Donepezil is combined with Lemborexant.]
[N05AD10, lumateperone, The risk or severity of adverse effects can be increased when Donepezil is combined with Lumateperone.]
[M01AX21, diacetylrhein, The metabolism of Donepezil can be decreased when combined with Diacerein.]
[H02CA02, osilodrostat, The metabolism of Donepezil can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Donepezil can be decreased when combined with Amprenavir.]
[N02CC07, frovatriptan, The risk or severity of adverse effects can be increased when Donepezil is combined with Frovatriptan.]
[N05CC04, dichloralphenazone, The risk or severity of adverse effects can be increased when Donepezil is combined with Dichloralphenazone.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Donepezil.]
[A07DA04, difenoxin, The risk or severity of adverse effects can be increased when Donepezil is combined with Difenoxin.]
[N02AA08, dihydrocodeine, The risk or severity of adverse effects can be increased when Donepezil is combined with Dihydrocodeine.]
[N02CC06, eletriptan, The risk or severity of adverse effects can be increased when Eletriptan is combined with Donepezil.]
[M01AH02, rofecoxib, The metabolism of Donepezil can be decreased when combined with Rofecoxib.]
[L01XF03, bexarotene, The metabolism of Donepezil can be decreased when combined with Bexarotene.]
[C08CA16, clevidipine, Donepezil may increase the neuromuscular blocking activities of Clevidipine.]
[C01BD07, dronedarone, The metabolism of Donepezil can be decreased when combined with Dronedarone.]
[N03AG02, dipropylacetamide, The risk or severity of adverse effects can be increased when Donepezil is combined with Valpromide.]
[N05BA02, chlordiazepoxide, The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Donepezil.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Donepezil.]
[A03AA08, dihexyverine, The therapeutic efficacy of Dihexyverine can be decreased when used in combination with Donepezil.]
[L01EX17, capmatinib, The serum concentration of Donepezil can be increased when it is combined with Capmatinib.]
[D07XB03, fluprednidene, The therapeutic efficacy of Donepezil can be decreased when used in combination with Fluprednidene.]
[G04BD09, trospium, The therapeutic efficacy of Trospium can be decreased when used in combination with Donepezil.]
[L01EX19, ripretinib, Ripretinib may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[N05CM02, chlormethiazole, The risk or severity of adverse effects can be increased when Donepezil is combined with Clomethiazole.]
[M03BB02, chlormezanone, The risk or severity of adverse effects can be increased when Donepezil is combined with Chlormezanone.]
[R02AD04, dyclonine, The risk or severity of adverse effects can be increased when Dyclonine is combined with Donepezil.]
[J05AX29, fostemsavir, Fostemsavir may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[P01BB01, proguanil, The metabolism of Donepezil can be decreased when combined with Proguanil.]
[N05CD14, remimazolam, The risk or severity of adverse effects can be increased when Donepezil is combined with Remimazolam.]
[N07XX04, sodium oxybate, Donepezil may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.]
[L04AC19, satralizumab, The serum concentration of Donepezil can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Donepezil is combined with Oliceridine.]
[P01BA01, chloroquine, The metabolism of Donepezil can be decreased when combined with Chloroquine.]
[L01EX23, pralsetinib, Pralsetinib may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[R06AB04, chlorpheniramine, The risk or severity of adverse effects can be increased when Donepezil is combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Donepezil.]
[A10BB02, chlorpropamide, The metabolism of Donepezil can be decreased when combined with Chlorpropamide.]
[N05AF03, chlorprothixene, The therapeutic efficacy of Chlorprothixene can be decreased when used in combination with Donepezil.]
[M03BB03, chlorzoxazone, The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Donepezil.]
[A11CC05, cholecalciferol, The metabolism of Donepezil can be decreased when combined with Cholecalciferol.]
[N05BX03, etifoxine, The risk or severity of adverse effects can be increased when Donepezil is combined with Etifoxine.]
[N06BX18, vinpocetine, The risk or severity of adverse effects can be increased when Donepezil is combined with Vinpocetine.]
[N05BA18, ethyl loflazepate, The risk or severity of adverse effects can be increased when Donepezil is combined with Ethyl loflazepate.]
[M01AB08, etodolac, The metabolism of Donepezil can be decreased when combined with Etodolac.]
[B06AC06, berotralstat, The metabolism of Donepezil can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Donepezil can be decreased when combined with Lonafarnib.]
[P03AX07, abametapir, The serum concentration of Donepezil can be increased when it is combined with Abametapir.]
[L01EX21, tepotinib, The metabolism of Donepezil can be decreased when combined with Tepotinib.]
[M03BA05, febarbamate, The risk or severity of adverse effects can be increased when Donepezil is combined with Febarbamate.]
[N03AX10, felbamate, The risk or severity of adverse effects can be increased when Donepezil is combined with Felbamate.]
[R03BA03, flunisolide, The therapeutic efficacy of Donepezil can be decreased when used in combination with Flunisolide.]
[S02BA08, fluocinolone acetonide, The therapeutic efficacy of Donepezil can be decreased when used in combination with Fluocinolone acetonide.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Donepezil.]
[L04AA50, ponesimod, The risk or severity of bradycardia can be increased when Ponesimod is combined with Donepezil.]
[L01EK03, tivozanib, Tivozanib may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[N01AB05, trichloroethylene, The risk or severity of adverse effects can be increased when Donepezil is combined with Trichloroethylene.]
[L03AB10, peginterferon alfa-2b, The metabolism of Donepezil can be decreased when combined with Peginterferon alfa-2b.]
[A02BA01, cimetidine, The metabolism of Donepezil can be decreased when combined with Cimetidine.]
[N02BF01, gabapentin, The risk or severity of adverse effects can be increased when Donepezil is combined with Gabapentin.]
[N07CA02, cinnarizine, Cinnarizine may increase the bradycardic activities of Donepezil.]
[L01XX73, sotorasib, The serum concentration of Donepezil can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Donepezil can be decreased when combined with Ciprofloxacin.]
[N06AB04, citalopram, The risk or severity of adverse effects can be increased when Donepezil is combined with Citalopram.]
[L04AA48, belumosudil, Belumosudil may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[P01CA03, fexinidazole, The risk or severity of adverse effects can be increased when Donepezil is combined with Fexinidazole.]
[R06AA04, clemastine, The risk or severity of adverse effects can be increased when Clemastine is combined with Donepezil.]
[M01AG01, mefenamic acid, The metabolism of Donepezil can be decreased when combined with Mefenamic acid.]
[A10BB12, glimepiride, The metabolism of Donepezil can be decreased when combined with Glimepiride.]
[A10BB08, gliquidone, The metabolism of Gliquidone can be decreased when combined with Donepezil.]
[N06AX25, St. John's wort extract, The metabolism of Donepezil can be increased when combined with St. John's Wort.]
[L01EA06, asciminib, The metabolism of Donepezil can be decreased when combined with Asciminib.]
[J05AX10, maribavir, Maribavir may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Donepezil.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Donepezil.]
[J04BA01, clofazimine, Clofazimine may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[N01BB10, levobupivacaine, The risk or severity of adverse effects can be increased when Donepezil is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The serum concentration of Donepezil can be increased when it is combined with Pacritinib.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Donepezil.]
[N03AE01, clonazepam, The risk or severity of adverse effects can be increased when Donepezil is combined with Clonazepam.]
[S01EA04, clonidine, The risk or severity of sedation can be increased when Clonidine is combined with Donepezil.]
[C01EB24, mavacamten, The serum concentration of Donepezil can be decreased when it is combined with Mavacamten.]
[J02AC06, oteseconazole, The serum concentration of Donepezil can be increased when it is combined with Oteseconazole.]
[N05AH06, clothiapine, The risk or severity of adverse effects can be increased when Donepezil is combined with Clothiapine.]
[N05BA21, clotiazepam, The risk or severity of adverse effects can be increased when Donepezil is combined with Clotiazepam.]
[A04AA01, ondansetron, The risk or severity of adverse effects can be increased when Donepezil is combined with Ondansetron.]
[A04AA02, granisetron, The risk or severity of adverse effects can be increased when Donepezil is combined with Granisetron.]
[N05AH02, clozapine, The therapeutic efficacy of Clozapine can be decreased when used in combination with Donepezil.]
[A10BK06, sotagliflozin, Sotagliflozin may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[N05BA13, halazepam, The risk or severity of adverse effects can be increased when Halazepam is combined with Donepezil.]
[H01AC08, somatrogon, The metabolism of Donepezil can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The therapeutic efficacy of Cocaine can be decreased when used in combination with Donepezil.]
[C02KB01, metyrosine, Donepezil may increase the sedative activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Donepezil can be increased when combined with Bimekizumab.]
[R05DA04, codeine, The risk or severity of adverse effects can be increased when Codeine is combined with Donepezil.]
[M03AC05, hexafluorenium, The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Donepezil.]
[A03AB10, hexocyclium, The therapeutic efficacy of Hexocyclium can be decreased when used in combination with Donepezil.]
[A03BB06, homatropine methylbromide, The therapeutic efficacy of Homatropine methylbromide can be decreased when used in combination with Donepezil.]
[S01FA05, homatropine, The therapeutic efficacy of Homatropine can be decreased when used in combination with Donepezil.]
[L04AA13, leflunomide, The metabolism of Donepezil can be decreased when combined with Leflunomide.]
[N01AB07, desflurane, The risk or severity of adverse effects can be increased when Donepezil is combined with Desflurane.]
[A04AA03, tropisetron, The risk or severity of adverse effects can be increased when Donepezil is combined with Tropisetron.]
[C04AX28, ifenprodil, The risk or severity of adverse effects can be increased when Donepezil is combined with Ifenprodil.]
[A10BX03, nateglinide, The metabolism of Donepezil can be decreased when combined with Nateglinide.]
[J01FA15, telithromycin, The metabolism of Donepezil can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The therapeutic efficacy of Donepezil can be decreased when used in combination with Ciclesonide.]
[R06AX27, desloratadine, The therapeutic efficacy of Desloratadine can be decreased when used in combination with Donepezil.]
[M01AH03, valdecoxib, The metabolism of Donepezil can be decreased when combined with Valdecoxib.]
[N02CC05, almotriptan, The risk or severity of adverse effects can be increased when Donepezil is combined with Almotriptan.]
[M01AH04, parecoxib, The metabolism of Parecoxib can be decreased when combined with Donepezil.]
[J02AC02, itraconazole, The metabolism of Donepezil can be decreased when combined with Itraconazole.]
[N05BA10, ketazolam, The risk or severity of adverse effects can be increased when Donepezil is combined with Ketazolam.]
[L01EA01, imatinib, The serum concentration of Donepezil can be increased when it is combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Donepezil can be decreased when combined with Posaconazole.]
[C08CA09, lacidipine, Donepezil may increase the bradycardic activities of Lacidipine.]
[N03AX09, lamotrigine, The therapeutic efficacy of Lamotrigine can be decreased when used in combination with Donepezil.]
[S01BA03, cortisone, The therapeutic efficacy of Donepezil can be decreased when used in combination with Cortisone.]
[N07BC04, lofexidine, The therapeutic efficacy of Donepezil can be increased when used in combination with Lofexidine.]
[N05CD06, lormetazepam, The risk or severity of adverse effects can be increased when Donepezil is combined with Lormetazepam.]
[C08CA11, manidipine, The metabolism of Donepezil can be decreased when combined with Manidipine.]
[A03AA04, mebeverine, The therapeutic efficacy of Mebeverine can be decreased when used in combination with Donepezil.]
[N06AX13, medifoxamine, The risk or severity of adverse effects can be increased when Donepezil is combined with Medifoxamine.]
[C07AA14, mepindolol, Donepezil may increase the bradycardic activities of Mepindolol.]
[H02AB15, meprednisone, The therapeutic efficacy of Donepezil can be decreased when used in combination with Meprednisone.]
[R06AD07, mequitazine, The metabolism of Mequitazine can be decreased when combined with Donepezil.]
[N04AA03, methixene, The therapeutic efficacy of Metixene can be decreased when used in combination with Donepezil.]
[C04AX01, cyclandelate, Donepezil may increase the bradycardic activities of Cyclandelate.]
[R06AE03, cyclizine, The risk or severity of adverse effects can be increased when Donepezil is combined with Cyclizine.]
[N05CA10, cyclobarbital, The risk or severity of adverse effects can be increased when Donepezil is combined with Cyclobarbital.]
[N05AD03, metylperon, The risk or severity of adverse effects can be increased when Donepezil is combined with Melperone.]
[S01FA04, cyclopentolate, The therapeutic efficacy of Cyclopentolate can be decreased when used in combination with Donepezil.]
[L01AA01, cyclophosphamide, The metabolism of Donepezil can be decreased when combined with Cyclophosphamide.]
[N06AX07, minaprine, The risk or severity of adverse effects can be increased when Minaprine is combined with Donepezil.]
[S01XA18, cyclosporine, The metabolism of Donepezil can be decreased when combined with Cyclosporine.]
[N06AG02, moclobemide, The risk or severity of adverse effects can be increased when Donepezil is combined with Moclobemide.]
[N06BA07, modafinil, The metabolism of Donepezil can be decreased when combined with Modafinil.]
[R06AX02, cyproheptadine, The therapeutic efficacy of Cyproheptadine can be decreased when used in combination with Donepezil.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be decreased when combined with Donepezil.]
[C03XA02, conivaptan, The metabolism of Donepezil can be decreased when combined with Conivaptan.]
[M01AH05, etoricoxib, The metabolism of Donepezil can be decreased when combined with Etoricoxib.]
[G03XA01, danazol, The metabolism of Donepezil can be decreased when combined with Danazol.]
[M03CA01, dantrolene, The risk or severity of adverse effects can be increased when Donepezil is combined with Dantrolene.]
[J04BA02, dapsone, The metabolism of Donepezil can be decreased when combined with Dapsone.]
[N06BX04, deanol, The risk or severity of adverse effects can be increased when Donepezil is combined with Deanol.]
[C02CC04, debrisoquin, The metabolism of Debrisoquine can be decreased when combined with Donepezil.]
[A04AD11, nabilone, Nabilone may increase the central nervous system depressant (CNS depressant) activities of Donepezil.]
[M01AX01, nabumetone, The metabolism of Donepezil can be decreased when combined with Nabumetone.]
[N05BA16, nordazepam, The risk or severity of adverse effects can be increased when Donepezil is combined with Nordazepam.]
[C07AB12, nebivolol, Donepezil may increase the bradycardic activities of Nebivolol.]
[N06AX06, nefazodone, The metabolism of Donepezil can be decreased when combined with Nefazodone.]
[N05CM16, niaprazine, The risk or severity of adverse effects can be increased when Donepezil is combined with Niaprazine.]
[L02BB02, nilutamide, The metabolism of Donepezil can be decreased when combined with Nilutamide.]
[N03AG06, tiagabine, The risk or severity of adverse effects can be increased when Donepezil is combined with Tiagabine.]
[M03AC11, cisatracurium, The therapeutic efficacy of Cisatracurium can be decreased when used in combination with Donepezil.]
[R05DA06, normethadone, The risk or severity of adverse effects can be increased when Donepezil is combined with Normethadone.]
[N06AB10, escitalopram, The therapeutic efficacy of Escitalopram can be decreased when used in combination with Donepezil.]
[G04BD08, solifenacin, The therapeutic efficacy of Solifenacin can be decreased when used in combination with Donepezil.]
[N06AA01, desipramine, The therapeutic efficacy of Desipramine can be decreased when used in combination with Donepezil.]
[D07XC02, desoximetasone, The therapeutic efficacy of Donepezil can be decreased when used in combination with Desoximetasone.]
[H02AA03, desoxycorticosterone, The therapeutic efficacy of Donepezil can be decreased when used in combination with Desoxycortone.]
[N03AF02, oxcarbazepine, The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Donepezil.]
[S03BA01, dexamethasone, The therapeutic efficacy of Donepezil can be decreased when used in combination with Dexamethasone.]
[N06BX07, oxiracetam, The risk or severity of adverse effects can be increased when Donepezil is combined with Oxiracetam.]
[N04AA08, dexetimide, The therapeutic efficacy of Dexetimide can be decreased when used in combination with Donepezil.]
[G04BD04, oxybutynin, The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Donepezil.]
[A08AA04, dexfenfluramine, The metabolism of Donepezil can be decreased when combined with Dexfenfluramine.]
[A03AA01, oxyphencyclimine, The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Donepezil.]
[L04AB04, adalimumab, The metabolism of Donepezil can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, Gefitinib may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[N06BA02, dextroamphetamine, The metabolism of Donepezil can be decreased when combined with Amphetamine.]
[R05DA09, dextromethorphan, The therapeutic efficacy of Dextromethorphan can be decreased when used in combination with Donepezil.]
[N03AC01, paramethadione, The risk or severity of adverse effects can be increased when Paramethadione is combined with Donepezil.]
[N02AC01, dextromoramide, The risk or severity of adverse effects can be increased when Donepezil is combined with Dextromoramide.]
[N06AB05, paroxetine, The therapeutic efficacy of Paroxetine can be decreased when used in combination with Donepezil.]
[B01AC04, clopidogrel, The metabolism of Donepezil can be decreased when combined with Clopidogrel.]
[N07BC06, heroin, The risk or severity of adverse effects can be increased when Donepezil is combined with Diamorphine.]
[N05BA01, diazepam, The risk or severity of adverse effects can be increased when Diazepam is combined with Donepezil.]
[N03AX07, phenacemide, The risk or severity of adverse effects can be increased when Donepezil is combined with Phenacemide.]
[N03AD02, phensuximide, The risk or severity of adverse effects can be increased when Phensuximide is combined with Donepezil.]
[N06AA08, dibenzepin, The risk or severity of adverse effects can be increased when Donepezil is combined with Dibenzepin.]
[S02DA04, dibucaine, The risk or severity of adverse effects can be increased when Cinchocaine is combined with Donepezil.]
[S01BC03, diclofenac, The metabolism of Donepezil can be decreased when combined with Diclofenac.]
[A03AA07, dicyclomine, The therapeutic efficacy of Dicyclomine can be decreased when used in combination with Donepezil.]
[A03AX04, pinaverium, Donepezil may increase the bradycardic activities of Pinaverium.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Donepezil is combined with Pipamperone.]
[A03AB14, pipenzolate, The therapeutic efficacy of Pipenzolate can be decreased when used in combination with Donepezil.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Donepezil.]
[A08AA03, diethylpropion, The risk or severity of adverse effects can be increased when Donepezil is combined with Diethylpropion.]
[L02AA01, diethylstilbestrol, Diethylstilbestrol may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[C08CA03, isradipine, The metabolism of Donepezil can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The therapeutic efficacy of Donepezil can be decreased when used in combination with Difluocortolone.]
[A03AB11, poldine, The therapeutic efficacy of Poldine can be decreased when used in combination with Donepezil.]
[C01AA05, digoxin, Digoxin may increase the bradycardic activities of Donepezil.]
[N02CA01, dihydroergotamine, The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Donepezil.]
[N02AA03, hydromorphone, The risk or severity of adverse effects can be increased when Hydromorphone is combined with Donepezil.]
[J05AE08, atazanavir, The metabolism of Donepezil can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, The metabolism of Donepezil can be decreased when combined with Treprostinil.]
[D04AB07, pramoxine, The risk or severity of adverse effects can be increased when Donepezil is combined with Pramocaine.]
[C08DB01, diltiazem, The metabolism of Donepezil can be decreased when combined with Diltiazem.]
[R06AA11, dimenhydrinate, The risk or severity of adverse effects can be increased when Donepezil is combined with Dimenhydrinate.]
[M03BX03, pridinol, The risk or severity of adverse effects can be increased when Donepezil is combined with Pridinol.]
[R06AB03, dimethindene, The therapeutic efficacy of Dimetindene can be decreased when used in combination with Donepezil.]
[M02AX03, dimethyl sulfoxide, The metabolism of Donepezil can be decreased when combined with Dimethyl sulfoxide.]
[N03AG05, progabide, The risk or severity of adverse effects can be increased when Progabide is combined with Donepezil.]
[C05CA03, diosmin, The metabolism of Donepezil can be decreased when combined with Diosmin.]
[R06AA02, diphenhydramine, The therapeutic efficacy of Diphenhydramine can be decreased when used in combination with Donepezil.]
[A07DA01, diphenoxylate, The risk or severity of adverse effects can be increased when Donepezil is combined with Diphenoxylate.]
[N05CD10, quazepam, The risk or severity of adverse effects can be increased when Donepezil is combined with Quazepam.]
[B01AC07, dipyridamole, The therapeutic efficacy of Donepezil can be decreased when used in combination with Dipyridamole.]
[N06BA11, dexmethylphenidate, The risk or severity of adverse effects can be increased when Donepezil is combined with Dexmethylphenidate.]
[N06AA23, quinupramine, The risk or severity of adverse effects can be increased when Donepezil is combined with Quinupramine.]
[A03FA02, cisapride, The metabolism of Donepezil can be decreased when combined with Cisapride.]
[N05AL04, remoxipride, The risk or severity of adverse effects can be increased when Remoxipride is combined with Donepezil.]
[C01BA03, disopyramide, The therapeutic efficacy of Disopyramide can be decreased when used in combination with Donepezil.]
[S02AA12, rifamycin SV, The metabolism of Donepezil can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Donepezil can be increased when combined with Rifapentine.]
[N07XX02, riluzole, The risk or severity of adverse effects can be increased when Riluzole is combined with Donepezil.]
[N05AX08, risperidone, The risk or severity of adverse effects can be increased when Risperidone is combined with Donepezil.]
[R06AE09, levocetirizine, The risk or severity of adverse effects can be increased when Donepezil is combined with Levocetirizine.]
[N01BB09, ropivacaine, The risk or severity of adverse effects can be increased when Ropivacaine is combined with Donepezil.]
[L01EX01, sunitinib, Sunitinib may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[A04AD12, aprepitant, The metabolism of Donepezil can be decreased when combined with Aprepitant.]
[L01XG01, bortezomib, The metabolism of Donepezil can be decreased when combined with Bortezomib.]
[S01BC05, ketorolac, The metabolism of Donepezil can be decreased when combined with Ketorolac.]
[C01EB18, ranolazine, The serum concentration of Donepezil can be increased when it is combined with Ranolazine.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Donepezil.]
[N06AA16, dothiepin, The therapeutic efficacy of Dosulepin can be decreased when used in combination with Donepezil.]
[N06AA12, doxepin, The therapeutic efficacy of Doxepin can be decreased when used in combination with Donepezil.]
[L01DB01, doxorubicin, The metabolism of Donepezil can be decreased when combined with Doxorubicin.]
[R06AA09, doxylamine, Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Donepezil.]
[N06AB06, sertraline, The risk or severity of adverse effects can be increased when Donepezil is combined with Sertraline.]
[N01AB08, sevoflurane, The risk or severity of adverse effects can be increased when Donepezil is combined with Sevoflurane.]
[N05AD08, droperidol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Donepezil.]
[A08AA10, sibutramine, The risk or severity of adverse effects can be increased when Donepezil is combined with Sibutramine.]
[C10AA01, simvastatin, The metabolism of Donepezil can be decreased when combined with Simvastatin.]
[N05AL02, sultopride, The risk or severity of adverse effects can be increased when Donepezil is combined with Sultopride.]
[N02CC01, sumatriptan, The risk or severity of adverse effects can be increased when Sumatriptan is combined with Donepezil.]
[C07AB13, talinolol, Donepezil may increase the bradycardic activities of Talinolol.]
[H01AA01, corticotropin, The therapeutic efficacy of Donepezil can be decreased when used in combination with Corticotropin.]
[M01AC02, tenoxicam, The metabolism of Donepezil can be decreased when combined with Tenoxicam.]
[D01BA02, terbinafine, The metabolism of Donepezil can be decreased when combined with Terbinafine.]
[G04BD05, terodiline, Donepezil may increase the bradycardic activities of Terodiline.]
[C07AA16, tertatolol, Donepezil may increase the bradycardic activities of Tertatolol.]
[M03BX07, tetrazepam, The risk or severity of adverse effects can be increased when Donepezil is combined with Tetrazepam.]
[M03BX05, thiocolchicoside, The risk or severity of adverse effects can be increased when Donepezil is combined with Thiocolchicoside.]
[N05AB05, thiopropazate, The risk or severity of adverse effects can be increased when Donepezil is combined with Thiopropazate.]
[G04BD01, emepronium, The therapeutic efficacy of Emepronium can be decreased when used in combination with Donepezil.]
[N06AX14, tianeptine, The risk or severity of adverse effects can be increased when Donepezil is combined with Tianeptine.]
[N05BA23, tofisopam, The risk or severity of adverse effects can be increased when Donepezil is combined with Tofisopam.]
[M01AG02, tolfenamic acid, Donepezil may increase the bradycardic activities of Tolfenamic acid.]
[N06AG03, toloxatone, The risk or severity of adverse effects can be increased when Donepezil is combined with Toloxatone.]
[N06BA09, atomoxetine, The metabolism of Donepezil can be decreased when combined with Atomoxetine.]
[N03AX11, topiramate, The risk or severity of adverse effects can be increased when Topiramate is combined with Donepezil.]
[C03CA04, torsemide, The metabolism of Donepezil can be decreased when combined with Torasemide.]
[N05CD11, triazulenone, The risk or severity of adverse effects can be increased when Donepezil is combined with Loprazolam.]
[N05CC01, chloral hydrate, The risk or severity of adverse effects can be increased when Donepezil is combined with Chloral hydrate.]
[N05CM07, triclofos, The risk or severity of adverse effects can be increased when Donepezil is combined with Triclofos.]
[A03AB08, tridihexethyl, The therapeutic efficacy of Tridihexethyl can be decreased when used in combination with Donepezil.]
[H02CA01, trilostane, The therapeutic efficacy of Donepezil can be decreased when used in combination with Trilostane.]
[R06AA10, trimethobenzamide, The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Donepezil.]
[N04AA12, tropatepine, The therapeutic efficacy of Tropatepine can be decreased when used in combination with Donepezil.]
[N01AB04, enflurane, The risk or severity of adverse effects can be increased when Enflurane is combined with Donepezil.]
[C02CA06, urapidil, The risk or severity of adverse effects can be increased when Donepezil is combined with Urapidil.]
[N05AL06, veralipride, The risk or severity of adverse effects can be increased when Donepezil is combined with Veralipride.]
[L01CA04, vinorelbine, The metabolism of Donepezil can be decreased when combined with Vinorelbine.]
[S01FB02, ephedrine, Donepezil may increase the neuromuscular blocking activities of Ephedrine.]
[S01GX10, epinastine, The risk or severity of adverse effects can be increased when Epinastine is combined with Donepezil.]
[N06AX16, venlafaxine, The metabolism of Donepezil can be decreased when combined with Venlafaxine.]
[C08CA12, mepirodipine, The metabolism of Donepezil can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The metabolism of Donepezil can be decreased when combined with Epinephrine.]
[N05CF02, zolpidem, Donepezil may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.]
[N03AX15, zonisamide, The risk or severity of adverse effects can be increased when Donepezil is combined with Zonisamide.]
[N05CF01, zopiclone, The risk or severity of adverse effects can be increased when Donepezil is combined with Zopiclone.]
[N05AX11, zotepine, The risk or severity of adverse effects can be increased when Donepezil is combined with Zotepine.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Donepezil is combined with Guanfacine.]
[C01BG01, moricizine, The risk or severity of adverse effects can be increased when Moricizine is combined with Donepezil.]
[G02AB03, ergonovine, The risk or severity of adverse effects can be increased when Donepezil is combined with Ergometrine.]
[C04AE01, ergoloid mesylates, USP, The risk or severity of adverse effects can be increased when Donepezil is combined with Ergoloid mesylate.]
[N02CA02, ergotamine, The metabolism of Donepezil can be decreased when combined with Ergotamine.]
[S01AA17, erythromycin, The metabolism of Donepezil can be decreased when combined with Erythromycin.]
[N05CD04, estazolam, The risk or severity of adverse effects can be increased when Donepezil is combined with Estazolam.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[H05BX01, cinacalcet, The metabolism of Donepezil can be decreased when combined with Cinacalcet.]
[G03CA03, estradiol, Estradiol may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[J04AK02, ethambutol, The metabolism of Donepezil can be decreased when combined with Ethambutol.]
[R03BA09, fluticasone furoate, The therapeutic efficacy of Donepezil can be decreased when used in combination with Fluticasone furoate.]
[R03BA05, fluticasone, The therapeutic efficacy of Donepezil can be decreased when used in combination with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Donepezil can be decreased when combined with Fluvastatin.]
[N05CM08, ethchlorvynol, The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Donepezil.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be decreased when combined with Donepezil.]
[N04AA05, profenamine, The therapeutic efficacy of Profenamine can be decreased when used in combination with Donepezil.]
[N03AD01, ethosuximide, The risk or severity of adverse effects can be increased when Ethosuximide is combined with Donepezil.]
[N03AB01, ethotoin, The risk or severity of adverse effects can be increased when Ethotoin is combined with Donepezil.]
[M01AC06, meloxicam, The metabolism of Donepezil can be decreased when combined with Meloxicam.]
[S01XA06, ethylmorphine, The risk or severity of adverse effects can be increased when Donepezil is combined with Ethylmorphine.]
[N01AX07, etomidate, The risk or severity of adverse effects can be increased when Etomidate is combined with Donepezil.]
[N05AE03, sertindole, The risk or severity of adverse effects can be increased when Donepezil is combined with Sertindole.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Donepezil.]
[R06AX12, terfenadine, The therapeutic efficacy of Terfenadine can be decreased when used in combination with Donepezil.]
[N06AX12, bupropion, The metabolism of Donepezil can be decreased when combined with Bupropion.]
[N06AB08, fluvoxamine, The metabolism of Donepezil can be decreased when combined with Fluvoxamine.]
[C01BC08, encainide, The metabolism of Encainide can be decreased when combined with Donepezil.]
[C10AA03, pravastatin, Pravastatin may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[C08CA02, felodipine, The metabolism of Donepezil can be decreased when combined with Felodipine.]
[C08EA01, fendiline, Donepezil may increase the bradycardic activities of Fendiline.]
[N03AX26, fenfluramine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Donepezil.]
[R03CC04, fenoterol, The therapeutic efficacy of Fenoterol can be decreased when used in combination with Donepezil.]
[N02AB03, fentanyl, The risk or severity of adverse effects can be increased when Fentanyl is combined with Donepezil.]
[N07AX03, cevimeline, The risk or severity of adverse effects can be increased when Donepezil is combined with Cevimeline.]
[G04BD02, flavoxate, The therapeutic efficacy of Flavoxate can be decreased when used in combination with Donepezil.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Donepezil.]
[J02AC01, fluconazole, The metabolism of Donepezil can be decreased when combined with Fluconazole.]
[H02AA02, fludrocortisone, The therapeutic efficacy of Donepezil can be decreased when used in combination with Fludrocortisone.]
[D07XB01, flumethasone, The therapeutic efficacy of Donepezil can be decreased when used in combination with Flumethasone.]
[N07CA03, flunarizine, The risk or severity of adverse effects can be increased when Donepezil is combined with Flunarizine.]
[N05CD03, flunitrazepam, The risk or severity of adverse effects can be increased when Donepezil is combined with Flunitrazepam.]
[D07AC08, fluocinonide, The therapeutic efficacy of Donepezil can be decreased when used in combination with Fluocinonide.]
[N06AA14, melitracen, The risk or severity of adverse effects can be increased when Donepezil is combined with Melitracen.]
[H02AB03, fluocortolone, The therapeutic efficacy of Donepezil can be decreased when used in combination with Fluocortolone.]
[V03AZ01, ethanol, Donepezil may increase the central nervous system depressant (CNS depressant) activities of Ethanol.]
[L01BC09, floxuridine, The metabolism of Donepezil can be decreased when combined with Floxuridine.]
[S01CB05, fluorometholone, The therapeutic efficacy of Donepezil can be decreased when used in combination with Fluorometholone.]
[L01BC02, fluorouracil, The metabolism of Donepezil can be decreased when combined with Fluorouracil.]
[N06AB03, fluoxetine, The therapeutic efficacy of Fluoxetine can be decreased when used in combination with Donepezil.]
[N05AF01, flupenthixol, Donepezil may increase the central nervous system depressant (CNS depressant) activities of Flupentixol.]
[N05AB02, fluphenazine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Donepezil.]
[N05CD01, flurazepam, The risk or severity of adverse effects can be increased when Flurazepam is combined with Donepezil.]
[S01BC04, flurbiprofen, The metabolism of Donepezil can be decreased when combined with Flurbiprofen.]
[N05AG01, fluspirilene, The risk or severity of adverse effects can be increased when Donepezil is combined with Fluspirilene.]
[M03AA01, alcuronium, The therapeutic efficacy of Alcuronium can be decreased when used in combination with Donepezil.]
[G01AX06, furazolidone, The risk or severity of adverse effects can be increased when Furazolidone is combined with Donepezil.]
[J05AE10, darunavir, The metabolism of Donepezil can be decreased when combined with Darunavir.]
[N05CF04, eszopiclone, The risk or severity of CNS depression can be increased when Donepezil is combined with Eszopiclone.]
[N05AL05, amisulpride, The risk or severity of adverse effects can be increased when Donepezil is combined with Amisulpride.]
[N06DA04, galantamine, Galantamine may increase the bradycardic activities of Donepezil.]
[M03AC02, gallamine, The therapeutic efficacy of Gallamine can be decreased when used in combination with Donepezil.]
[C08DA02, gallopamil, Donepezil may increase the bradycardic activities of Gallopamil.]
[N03AA04, barbexaclone, The risk or severity of adverse effects can be increased when Donepezil is combined with Barbexaclone.]
[N06AX08, bifemelane, The risk or severity of adverse effects can be increased when Donepezil is combined with Bifemelane.]
[C10AB04, gemfibrozil, The metabolism of Donepezil can be decreased when combined with Gemfibrozil.]
[L01EA02, dasatinib, Dasatinib may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[N04BC06, cabergoline, The risk or severity of adverse effects can be increased when Cabergoline is combined with Donepezil.]
[J05AG04, etravirine, The metabolism of Donepezil can be decreased when combined with Etravirine.]
[N03AD03, methsuximide, The risk or severity of adverse effects can be increased when Donepezil is combined with Methsuximide.]
[N01AH02, alfentanil, The risk or severity of adverse effects can be increased when Alfentanil is combined with Donepezil.]
[A10BB01, glyburide, The metabolism of Donepezil can be decreased when combined with Glyburide.]
[A10BB09, gliclazide, The metabolism of Gliclazide can be decreased when combined with Donepezil.]
[A10BB07, glipizide, The metabolism of Glipizide can be decreased when combined with Donepezil.]
[N05CM18, dexmedetomidine, The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Donepezil.]
[N05CE01, glutethimide, The risk or severity of adverse effects can be increased when Donepezil is combined with Glutethimide.]
[C02CA04, doxazosin, The metabolism of Donepezil can be decreased when combined with Doxazosin.]
[L01EX02, sorafenib, The metabolism of Donepezil can be decreased when combined with Sorafenib.]
[C07AB09, esmolol, Donepezil may increase the bradycardic activities of Esmolol.]
[B01AA12, fluindione, The metabolism of Fluindione can be decreased when combined with Donepezil.]
[P01BX01, halofantrine, The metabolism of Donepezil can be decreased when combined with Halofantrine.]
[N05AD01, haloperidol, The risk or severity of CNS depression can be increased when Haloperidol is combined with Donepezil.]
[N01AB01, halothane, The risk or severity of adverse effects can be increased when Donepezil is combined with Halothane.]
[N05AH04, quetiapine, The therapeutic efficacy of Quetiapine can be decreased when used in combination with Donepezil.]
[N02CX03, iprazochrome, The risk or severity of adverse effects can be increased when Donepezil is combined with Iprazochrome.]
[L01CE02, irinotecan, Donepezil may increase the neuromuscular blocking activities of Irinotecan.]
[N05CA21, allobarbital, The risk or severity of adverse effects can be increased when Donepezil is combined with Allobarbital.]
[C09CA01, losartan, The metabolism of Donepezil can be decreased when combined with Losartan.]
[N05CA16, hexobarbital, The therapeutic efficacy of Hexobarbital can be decreased when used in combination with Donepezil.]
[J05AG01, nevirapine, The metabolism of Donepezil can be decreased when combined with Nevirapine.]
[C08CA10, nilvadipine, The metabolism of Donepezil can be decreased when combined with Nilvadipine.]
[M02AA26, nimesulide, Donepezil may increase the bradycardic activities of Nimesulide.]
[R05DA03, hydrocodone, Donepezil may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[S02BA01, hydrocortisone, The therapeutic efficacy of Donepezil can be decreased when used in combination with Hydrocortisone.]
[G04BD06, propiverine, The therapeutic efficacy of Propiverine can be decreased when used in combination with Donepezil.]
[P01BA02, hydroxychloroquine, The metabolism of Donepezil can be decreased when combined with Hydroxychloroquine.]
[N05AX07, prothipendyl, The risk or severity of adverse effects can be increased when Donepezil is combined with Prothipendyl.]
[N05BB01, hydroxyzine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Donepezil.]
[R02AX02, ibuprofen, The metabolism of Ibuprofen can be decreased when combined with Donepezil.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Donepezil.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Donepezil.]
[N01AH03, sufentanil, The risk or severity of adverse effects can be increased when Sufentanil is combined with Donepezil.]
[N06AA02, imipramine, The therapeutic efficacy of Imipramine can be decreased when used in combination with Donepezil.]
[R01AD07, tixocortol, The therapeutic efficacy of Donepezil can be decreased when used in combination with Tixocortol.]
[M03BX02, tizanidine, The risk or severity of adverse effects can be increased when Tizanidine is combined with Donepezil.]
[S01BC01, indomethacin, The metabolism of Donepezil can be decreased when combined with Indomethacin.]
[N06AX17, milnacipran, The risk or severity of adverse effects can be increased when Donepezil is combined with Milnacipran.]
[A03AA30, piperidolate, The therapeutic efficacy of Piperidolate can be decreased when used in combination with Donepezil.]
[S01XA28, varenicline, The risk or severity of adverse effects can be increased when Donepezil is combined with Varenicline.]
[N01BB08, articaine, The risk or severity of adverse effects can be increased when Donepezil is combined with Articaine.]
[N05BA12, alprazolam, The risk or severity of adverse effects can be increased when Alprazolam is combined with Donepezil.]
[N05CH02, ramelteon, The risk or severity of adverse effects can be increased when Donepezil is combined with Ramelteon.]
[R06AE01, buclizine, The therapeutic efficacy of Buclizine can be decreased when used in combination with Donepezil.]
[C10AA06, cerivastatin, The metabolism of Donepezil can be decreased when combined with Cerivastatin.]
[C07AA01, alprenolol, Donepezil may increase the bradycardic activities of Alprenolol.]
[V03AB01, ipecac, The metabolism of Ipecac can be decreased when combined with Donepezil.]
[N06AA13, iprindole, The risk or severity of adverse effects can be increased when Donepezil is combined with Iprindole.]
[N06AF05, iproniazid, The risk or severity of adverse effects can be increased when Donepezil is combined with Iproniazid.]
[N05AA07, chlorproethazine, The risk or severity of adverse effects can be increased when Donepezil is combined with Chlorproethazine.]
[N06AF01, isocarboxazid, The risk or severity of adverse effects can be increased when Donepezil is combined with Isocarboxazid.]
[P01AX06, atovaquone, The metabolism of Donepezil can be decreased when combined with Atovaquone.]
[N01AB06, isoflurane, The therapeutic efficacy of Isoflurane can be decreased when used in combination with Donepezil.]
[N04BX02, entacapone, The risk or severity of adverse effects can be increased when Entacapone is combined with Donepezil.]
[J04AC01, isoniazid, The metabolism of Donepezil can be decreased when combined with Isoniazid.]
[N06AX18, reboxetine, The risk or severity of adverse effects can be increased when Reboxetine is combined with Donepezil.]
[L04AC07, tocilizumab, The metabolism of Donepezil can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The risk or severity of adverse effects can be increased when Donepezil is combined with Ketamine.]
[C02KD01, ketanserin, The risk or severity of adverse effects can be increased when Donepezil is combined with Ketanserin.]
[B01AC22, prasugrel, The metabolism of Prasugrel can be decreased when combined with Donepezil.]
[J02AB02, ketoconazole, The metabolism of Donepezil can be decreased when combined with Ketoconazole.]
[H02CA04, levoketoconazole, The metabolism of Donepezil can be decreased when combined with Levoketoconazole.]
[N05AH03, olanzapine, The therapeutic efficacy of Olanzapine can be decreased when used in combination with Donepezil.]
[L04AA24, abatacept, The metabolism of Donepezil can be increased when combined with Abatacept.]
[N04BC09, rotigotine, Donepezil may increase the sedative activities of Rotigotine.]
[C07AG01, labetalol, Donepezil may increase the bradycardic activities of Labetalol.]
[N04BB01, amantadine, The therapeutic efficacy of Amantadine can be decreased when used in combination with Donepezil.]
[N03AX18, lacosamide, The risk or severity of adverse effects can be increased when Donepezil is combined with Lacosamide.]
[N04BA01, levodopa, The risk or severity of adverse effects can be increased when Donepezil is combined with Levodopa.]
[S02DA01, lidocaine, The risk or severity of adverse effects can be increased when Lidocaine is combined with Donepezil.]
[C08EX01, lidoflazine, Donepezil may increase the bradycardic activities of Lidoflazine.]
[N06BA13, armodafinil, The metabolism of Donepezil can be decreased when combined with Armodafinil.]
[N02CA07, lisuride, The risk or severity of adverse effects can be increased when Lisuride is combined with Donepezil.]
[N06AA07, lofepramine, The risk or severity of adverse effects can be increased when Donepezil is combined with Lofepramine.]
[A07DA03, loperamide, Loperamide may increase the bradycardic activities of Donepezil.]
[N05BA06, lorazepam, The risk or severity of adverse effects can be increased when Lorazepam is combined with Donepezil.]
[C10AA02, lovastatin, The metabolism of Donepezil can be decreased when combined with Lovastatin.]
[N05AH01, loxapine, The risk or severity of adverse effects can be increased when Loxapine is combined with Donepezil.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Donepezil.]
[L01EG01, temsirolimus, The metabolism of Donepezil can be decreased when combined with Temsirolimus.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Donepezil can be increased when used in combination with Magnesium sulfate.]
[L01EA03, nilotinib, The metabolism of Donepezil can be decreased when combined with Nilotinib.]
[N06AA21, maprotiline, The therapeutic efficacy of Maprotiline can be decreased when used in combination with Donepezil.]
[A08AA05, mazindol, The risk or severity of adverse effects can be increased when Mazindol is combined with Donepezil.]
[C02BB01, mecamylamine, The therapeutic efficacy of Mecamylamine can be decreased when used in combination with Donepezil.]
[R06AE05, meclizine, The therapeutic efficacy of Meclizine can be decreased when used in combination with Donepezil.]
[N05BA03, medazepam, The risk or severity of adverse effects can be increased when Donepezil is combined with Medazepam.]
[N05CH01, melatonin, The risk or severity of adverse effects can be increased when Donepezil is combined with Melatonin.]
[N02AB02, meperidine, The risk or severity of adverse effects can be increased when Meperidine is combined with Donepezil.]
[N03AB04, mephenytoin, The risk or severity of adverse effects can be increased when Mephenytoin is combined with Donepezil.]
[N03AA01, mephobarbital, The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Donepezil.]
[N01BB03, mepivacaine, The risk or severity of adverse effects can be increased when Donepezil is combined with Mepivacaine.]
[N05BC01, meprobamate, The risk or severity of adverse effects can be increased when Meprobamate is combined with Donepezil.]
[N02AX05, meptazinol, The risk or severity of adverse effects can be increased when Donepezil is combined with Meptazinol.]
[N05AC03, mesoridazine, The risk or severity of adverse effects can be increased when Donepezil is combined with Mesoridazine.]
[N05AX13, paliperidone, The risk or severity of adverse effects can be increased when Donepezil is combined with Paliperidone.]
[A04AA04, dolasetron, The risk or severity of adverse effects can be increased when Dolasetron is combined with Donepezil.]
[H01CB03, lanreotide, Donepezil may increase the bradycardic activities of Lanreotide.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Methadone is combined with Donepezil.]
[N06BA03, methamphetamine, The risk or severity of adverse effects can be increased when Donepezil is combined with Metamfetamine.]
[A03AB07, methantheline, The therapeutic efficacy of Methantheline can be decreased when used in combination with Donepezil.]
[R06AC05, methapyrilene, The risk or severity of adverse effects can be increased when Donepezil is combined with Methapyrilene.]
[N05CM01, methaqualone, The risk or severity of adverse effects can be increased when Donepezil is combined with Methaqualone.]
[N03AA30, metharbital, The therapeutic efficacy of Metharbital can be decreased when used in combination with Donepezil.]
[G02CB05, metergoline, The risk or severity of adverse effects can be increased when Donepezil is combined with Metergoline.]
[H03BB02, methimazole, The metabolism of Donepezil can be decreased when combined with Methimazole.]
[M03BA03, methocarbamol, The risk or severity of adverse effects can be increased when Methocarbamol is combined with Donepezil.]
[N05CA15, methohexital, The risk or severity of adverse effects can be increased when Methohexital is combined with Donepezil.]
[N02BG08, ziconotide, The risk or severity of adverse effects can be increased when Donepezil is combined with Ziconotide.]
[N05AA02, methotrimeprazine, The therapeutic efficacy of Methotrimeprazine can be decreased when used in combination with Donepezil.]
[N02BG09, methoxyflurane, The risk or severity of adverse effects can be increased when Donepezil is combined with Methoxyflurane.]
[C02AB01, methyldopa, Donepezil may increase the bradycardic activities of Methyldopa.]
[V04CG05, methylene blue, The risk or severity of adverse effects can be increased when Donepezil is combined with Methylene blue.]
[H02AB04, methylprednisolone, The therapeutic efficacy of Donepezil can be decreased when used in combination with Methylprednisolone.]
[D07AC14, methylprednisolone aceponate, The therapeutic efficacy of Donepezil can be decreased when used in combination with Methylprednisolone aceponate.]
[N03AF03, rufinamide, The risk or severity of adverse effects can be increased when Rufinamide is combined with Donepezil.]
[N05CE02, methyprylon, The risk or severity of adverse effects can be increased when Donepezil is combined with Methyprylon.]
[N02CA04, methysergide, The risk or severity of adverse effects can be increased when Methysergide is combined with Donepezil.]
[A03FA01, metoclopramide, The risk or severity of sedation can be increased when Metoclopramide is combined with Donepezil.]
[C07AB02, metoprolol, The metabolism of Donepezil can be decreased when combined with Metoprolol.]
[P01AB01, metronidazole, The metabolism of Donepezil can be decreased when combined with Metronidazole.]
[C01BB02, mexiletine, The metabolism of Donepezil can be decreased when combined with Mexiletine.]
[N06AX03, mianserin, The risk or severity of adverse effects can be increased when Donepezil is combined with Mianserin.]
[S02AA13, miconazole, The metabolism of Donepezil can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Donepezil.]
[N05CD08, midazolam, The risk or severity of adverse effects can be increased when Midazolam is combined with Donepezil.]
[C01CA17, midodrine, Midodrine may increase the bradycardic activities of Donepezil.]
[G03XB01, mifepristone, The metabolism of Donepezil can be decreased when combined with Mifepristone.]
[C09CA03, valsartan, The metabolism of Donepezil can be decreased when combined with Valsartan.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Donepezil.]
[L01XX23, mitotane, The metabolism of Donepezil can be increased when combined with Mitotane.]
[N06BA12, lisdexamfetamine, The metabolism of Donepezil can be decreased when combined with Lisdexamfetamine.]
[N05AE02, molindone, The risk or severity of adverse effects can be increased when Donepezil is combined with Molindone.]
[C01BD01, amiodarone, The metabolism of Donepezil can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The therapeutic efficacy of Amitriptyline can be decreased when used in combination with Donepezil.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Morphine is combined with Donepezil.]
[A04AA05, palonosetron, The risk or severity of adverse effects can be increased when Palonosetron is combined with Donepezil.]
[L04AB05, certolizumab pegol, The metabolism of Donepezil can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, Eltrombopag may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[L01EX03, pazopanib, The metabolism of Donepezil can be decreased when combined with Pazopanib.]
[M03AC03, vecuronium, The therapeutic efficacy of Vecuronium can be decreased when used in combination with Donepezil.]
[N05CA02, amobarbital, The therapeutic efficacy of Amobarbital can be decreased when used in combination with Donepezil.]
[P01BA06, amodiaquine, The metabolism of Donepezil can be decreased when combined with Amodiaquine.]
[R03BB01, ipratropium bromide, The therapeutic efficacy of Ipratropium can be decreased when used in combination with Donepezil.]
[N06AA17, amoxapine, The therapeutic efficacy of Amoxapine can be decreased when used in combination with Donepezil.]
[N03AB05, fosphenytoin, The metabolism of Donepezil can be increased when combined with Fosphenytoin.]
[C07AA12, nadolol, Donepezil may increase the bradycardic activities of Nadolol.]
[N04BC04, ropinirole, Donepezil may increase the sedative activities of Ropinirole.]
[C04AX21, nafronyl, The risk or severity of adverse effects can be increased when Donepezil is combined with Naftidrofuryl.]
[N02AF02, nalbuphine, The risk or severity of adverse effects can be increased when Donepezil is combined with Nalbuphine.]
[V03AB15, naloxone, The metabolism of Donepezil can be decreased when combined with Naloxone.]
[N07BB04, naltrexone, The risk or severity of respiratory depression can be increased when Naltrexone is combined with Donepezil.]
[L04AC03, anakinra, The metabolism of Donepezil can be increased when combined with Anakinra.]
[N06BA01, amphetamine, The metabolism of Donepezil can be decreased when combined with Amphetamine.]
[M02AA12, naproxen, The metabolism of Donepezil can be decreased when combined with Naproxen.]
[A10BG01, troglitazone, The metabolism of Donepezil can be decreased when combined with Troglitazone.]
[N06AX21, duloxetine, The metabolism of Donepezil can be decreased when combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Tolcapone is combined with Donepezil.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Donepezil is combined with Remifentanil.]
[N05AX14, iloperidone, The risk or severity of adverse effects can be increased when Donepezil is combined with Iloperidone.]
[N06AX23, desvenlafaxine, The risk or severity of adverse effects can be increased when Donepezil is combined with Desvenlafaxine.]
[C09CA07, telmisartan, Telmisartan may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[M04AA03, febuxostat, The excretion of Donepezil can be decreased when combined with Febuxostat.]
[C10AD02, niacin, The metabolism of Donepezil can be decreased when combined with Niacin.]
[N06AF02, nialamide, The risk or severity of adverse effects can be increased when Donepezil is combined with Nialamide.]
[C08CA04, nicardipine, The therapeutic efficacy of Nicardipine can be decreased when used in combination with Donepezil.]
[C04AE02, nicergoline, The metabolism of Donepezil can be decreased when combined with Nicergoline.]
[P02DA01, niclosamide, The metabolism of Niclosamide can be decreased when combined with Donepezil.]
[N07BA01, nicotine, The risk or severity of adverse effects can be increased when Donepezil is combined with Nicotine.]
[C08CA05, nifedipine, Donepezil may increase the bradycardic activities of Nifedipine.]
[C08CA06, nimodipine, Nimodipine may increase the bradycardic activities of Donepezil.]
[C08CA07, nisoldipine, Nisoldipine may increase the bradycardic activities of Donepezil.]
[N05CD02, nitrazepam, The risk or severity of adverse effects can be increased when Donepezil is combined with Nitrazepam.]
[C08CA08, nitrendipine, Donepezil may increase the bradycardic activities of Nitrendipine.]
[N05CF03, zaleplon, The risk or severity of adverse effects can be increased when Donepezil is combined with Zaleplon.]
[N04BC05, pramipexole, Donepezil may increase the sedative activities of Pramipexole.]
[N01AX13, nitrous oxide, The risk or severity of adverse effects can be increased when Donepezil is combined with Nitrous oxide.]
[N06AX04, nomifensine, The risk or severity of adverse effects can be increased when Donepezil is combined with Nomifensine.]
[C02KX01, bosentan, The metabolism of Donepezil can be increased when combined with Bosentan.]
[N06AA10, nortriptyline, The therapeutic efficacy of Nortriptyline can be decreased when used in combination with Donepezil.]
[R05DA07, noscapine, The metabolism of Donepezil can be decreased when combined with Noscapine.]
[G02CA02, nylidrin, Donepezil may increase the bradycardic activities of Nylidrin.]
[H01CB02, octreotide, The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Donepezil.]
[L04AC04, rilonacept, The metabolism of Donepezil can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, Omeprazole may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[N06AA05, opipramol, The risk or severity of adverse effects can be increased when Donepezil is combined with Opipramol.]
[N02AA02, opium, The risk or severity of adverse effects can be increased when Donepezil is combined with Opium.]
[G04CA02, tamsulosin, The metabolism of Donepezil can be decreased when combined with Tamsulosin.]
[P02BA02, oxamniquine, The metabolism of Donepezil can be decreased when combined with Oxamniquine.]
[A14AA08, oxandrolone, The metabolism of Donepezil can be decreased when combined with Oxandrolone.]
[N05BA04, oxazepam, The risk or severity of adverse effects can be increased when Oxazepam is combined with Donepezil.]
[C07AA02, oxprenolol, Donepezil may increase the bradycardic activities of Oxprenolol.]
[N02AA05, oxycodone, The risk or severity of adverse effects can be increased when Oxycodone is combined with Donepezil.]
[N02AA11, oxymorphone, The risk or severity of adverse effects can be increased when Donepezil is combined with Oxymorphone.]
[N05AE01, oxypertine, The risk or severity of adverse effects can be increased when Donepezil is combined with Oxypertine.]
[A03AB03, oxyphenonium, The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Donepezil.]
[N05AH05, asenapine, The risk or severity of adverse effects can be increased when Donepezil is combined with Asenapine.]
[N02AX06, tapentadol, Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Donepezil.]
[M03AC01, pancuronium, The therapeutic efficacy of Pancuronium can be decreased when used in combination with Donepezil.]
[N05CC05, paraldehyde, Donepezil may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.]
[H02AB05, paramethasone, The therapeutic efficacy of Donepezil can be decreased when used in combination with Paramethasone.]
[C02KC01, pargyline, The risk or severity of adverse effects can be increased when Donepezil is combined with Pargyline.]
[G04BD11, fesoterodine, The therapeutic efficacy of Fesoterodine can be decreased when used in combination with Donepezil.]
[C07AA23, penbutolol, Donepezil may increase the bradycardic activities of Penbutolol.]
[N05AG03, penfluridol, The risk or severity of adverse effects can be increased when Donepezil is combined with Penfluridol.]
[N02AD01, pentazocine, The risk or severity of adverse effects can be increased when Pentazocine is combined with Donepezil.]
[N05CA01, pentobarbital, The therapeutic efficacy of Pentobarbital can be decreased when used in combination with Donepezil.]
[N05AB10, perazine, The risk or severity of adverse effects can be increased when Donepezil is combined with Perazine.]
[N04BC02, pergolide, The risk or severity of adverse effects can be increased when Donepezil is combined with Pergolide.]
[C08EX02, perhexiline, The metabolism of Donepezil can be decreased when combined with Perhexiline.]
[N05AB03, perphenazine, The risk or severity of adverse effects can be increased when Donepezil is combined with Perphenazine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Donepezil.]
[N02AD02, phenazocine, The risk or severity of adverse effects can be increased when Donepezil is combined with Phenazocine.]
[N06AF03, phenelzine, The risk or severity of adverse effects can be increased when Phenelzine is combined with Donepezil.]
[A10BA01, phenformin, The metabolism of Phenformin can be decreased when combined with Donepezil.]
[N03AA02, phenobarbital, The therapeutic efficacy of Phenobarbital can be decreased when used in combination with Donepezil.]
[N01AH04, phenoperidine, The risk or severity of adverse effects can be increased when Donepezil is combined with Phenoperidine.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Donepezil.]
[M02AA01, phenylbutazone, The metabolism of Donepezil can be decreased when combined with Phenylbutazone.]
[N03AB02, phenytoin, The metabolism of Donepezil can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Donepezil can be increased when combined with Golimumab.]
[C08CX01, mibefradil, The metabolism of Donepezil can be decreased when combined with Mibefradil.]
[S01EB01, pilocarpine, The risk or severity of adverse effects can be increased when Donepezil is combined with Pilocarpine.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Donepezil.]
[C07AA03, pindolol, Donepezil may increase the bradycardic activities of Pindolol.]
[J05AE01, saquinavir, The metabolism of Donepezil can be decreased when combined with Saquinavir.]
[P02CB01, piperazine, The metabolism of Donepezil can be decreased when combined with Piperazine.]
[N05AC04, pipothiazine, The risk or severity of adverse effects can be increased when Donepezil is combined with Pipotiazine.]
[A02BX03, pirenzepine, The therapeutic efficacy of Pirenzepine can be decreased when used in combination with Donepezil.]
[N02AC03, pirinitramide, The risk or severity of adverse effects can be increased when Donepezil is combined with Piritramide.]
[S01BC06, piroxicam, The metabolism of Donepezil can be decreased when combined with Piroxicam.]
[N02CX01, pizotyline, The therapeutic efficacy of Pizotifen can be decreased when used in combination with Donepezil.]
[J05AG02, delavirdine, The metabolism of Donepezil can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Irbesartan can be decreased when combined with Donepezil.]
[N05CA22, proxibarbal, The risk or severity of adverse effects can be increased when Donepezil is combined with Proxibarbal.]
[A10BG02, rosiglitazone, The metabolism of Donepezil can be decreased when combined with Rosiglitazone.]
[A03AE01, alosetron, The risk or severity of adverse effects can be increased when Donepezil is combined with Alosetron.]
[L04AC08, canakinumab, The metabolism of Donepezil can be increased when combined with Canakinumab.]
[J05AE03, ritonavir, The serum concentration of Donepezil can be increased when it is combined with Ritonavir.]
[C10AA08, pitavastatin, The metabolism of Pitavastatin can be decreased when combined with Donepezil.]
[C07AB01, practolol, Donepezil may increase the bradycardic activities of Practolol.]
[N05BA11, prazepam, The risk or severity of adverse effects can be increased when Donepezil is combined with Prazepam.]
[S03BA02, prednisolone, The therapeutic efficacy of Donepezil can be decreased when used in combination with Prednisolone.]
[H02AB07, prednisone, The therapeutic efficacy of Donepezil can be decreased when used in combination with Prednisone.]
[C01DX02, prenylamine, Donepezil may increase the bradycardic activities of Prenylamine.]
[N01BB04, prilocaine, The risk or severity of adverse effects can be increased when Prilocaine is combined with Donepezil.]
[P01BA03, primaquine, The metabolism of Donepezil can be decreased when combined with Primaquine.]
[N03AA03, primidone, The therapeutic efficacy of Primidone can be decreased when used in combination with Donepezil.]
[M04AB01, probenecid, The metabolism of Donepezil can be decreased when combined with Probenecid.]
[C01BA02, procainamide, The metabolism of Procainamide can be decreased when combined with Donepezil.]
[S01HA05, procaine, The therapeutic efficacy of Procaine can be decreased when used in combination with Donepezil.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Donepezil is combined with Procarbazine.]
[C10AB05, fenofibrate, The metabolism of Donepezil can be decreased when combined with Fenofibrate.]
[N05AB04, prochlorperazine, The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Donepezil.]
[N04AA04, procyclidine, The therapeutic efficacy of Procyclidine can be decreased when used in combination with Donepezil.]
[G03DA04, progesterone, Progesterone may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[N05AA03, promazine, The therapeutic efficacy of Promazine can be decreased when used in combination with Donepezil.]
[R06AD02, promethazine, The therapeutic efficacy of Promethazine can be decreased when used in combination with Donepezil.]
[C01BC03, propafenone, The metabolism of Donepezil can be decreased when combined with Propafenone.]
[N01AX04, propanidid, The risk or severity of adverse effects can be increased when Donepezil is combined with Propanidid.]
[A03AB05, propantheline, The therapeutic efficacy of Propantheline can be decreased when used in combination with Donepezil.]
[N05AC01, periciazine, The risk or severity of adverse effects can be increased when Donepezil is combined with Periciazine.]
[N05CM06, propiomazine, The therapeutic efficacy of Propiomazine can be decreased when used in combination with Donepezil.]
[N01AX10, propofol, The risk or severity of adverse effects can be increased when Propofol is combined with Donepezil.]
[N02AC04, propoxyphene, The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Donepezil.]
[C07AA05, propranolol, Donepezil may increase the bradycardic activities of Propranolol.]
[N02CC04, rizatriptan, The risk or severity of adverse effects can be increased when Donepezil is combined with Rizatriptan.]
[R03DC03, montelukast, The metabolism of Donepezil can be decreased when combined with Montelukast.]
[N06AA11, protriptyline, The risk or severity of adverse effects can be increased when Protriptyline is combined with Donepezil.]
[N05AX12, aripiprazole, The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Donepezil.]
[A03AB15, diphemanil, The therapeutic efficacy of Diphemanil can be decreased when used in combination with Donepezil.]
[A03AB09, isopropamide, The therapeutic efficacy of Isopropamide can be decreased when used in combination with Donepezil.]
[S01FA03, methscopolamine, The therapeutic efficacy of Methscopolamine can be decreased when used in combination with Donepezil.]
[N05CA07, talbutal, The therapeutic efficacy of Talbutal can be decreased when used in combination with Donepezil.]
[N05CA09, vinbarbital, The risk or severity of adverse effects can be increased when Donepezil is combined with Vinbarbital.]
[N05BB02, captodiamine, The risk or severity of adverse effects can be increased when Donepezil is combined with Captodiame.]
[M03BA04, styramate, The risk or severity of adverse effects can be increased when Donepezil is combined with Styramate.]
[P02CC01, pyrantel, The risk or severity of adverse effects can be increased when Donepezil is combined with Pyrantel.]
[R06AC01, pyrilamine, The risk or severity of adverse effects can be increased when Donepezil is combined with Mepyramine.]
[C01BA01, quinidine, The therapeutic efficacy of Quinidine can be decreased when used in combination with Donepezil.]
[P01BC01, quinine, The metabolism of Donepezil can be decreased when combined with Quinine.]
[A02BA02, ranitidine, The metabolism of Donepezil can be decreased when combined with Ranitidine.]
[C02AA02, reserpine, The risk or severity of adverse effects can be increased when Reserpine is combined with Donepezil.]
[J04AB02, rifampin, The metabolism of Donepezil can be increased when combined with Rifampicin.]
[N06AX01, 5-hydroxytryptophan, The risk or severity of adverse effects can be increased when Donepezil is combined with Oxitriptan.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[S01BC08, salicylic acid, The metabolism of Salicylic acid can be decreased when combined with Donepezil.]
[S01FA02, scopolamine, The therapeutic efficacy of Scopolamine can be decreased when used in combination with Donepezil.]
[N05CA06, secobarbital, The therapeutic efficacy of Secobarbital can be decreased when used in combination with Donepezil.]
[N04BD01, selegiline, The risk or severity of adverse effects can be increased when Donepezil is combined with Selegiline.]
[C07AA07, sotalol, The metabolism of Sotalol can be decreased when combined with Donepezil.]
[L01CD04, cabazitaxel, Cabazitaxel may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[N03AG01, valproic acid, The risk or severity of adverse effects can be increased when Valproic acid is combined with Donepezil.]
[D07AB02, hydrocortisone butyrate, The therapeutic efficacy of Donepezil can be decreased when used in combination with Hydrocortisone butyrate.]
[N05AL01, sulpiride, QT prolonging agents - QT prolonging agents]
[N05AC02, thioridazine, QT prolonging agents - QT prolonging agents]
[L01EX04, vandetanib, QT prolonging agents - QT prolonging agents]
[S01AE07, moxifloxacin, QT prolonging agents - QT prolonging agents]
[C08EA02, bepridil, QT prolonging agents - QT prolonging agents]
[L01XX27, arsenic trioxide, QT prolonging agents - QT prolonging agents]
[J01MA09, sparfloxacin, QT prolonging agents - QT prolonging agents]
[S01AA26, azithromycin, QT prolonging agents - QT prolonging agents]
[B01AC23, cilostazol, QT prolonging agents - QT prolonging agents]
[J01FA09, clarithromycin, QT prolonging agents - QT prolonging agents]
[S01AE06, gatifloxacin, QT prolonging agents - QT prolonging agents]
[C01BD07, dronedarone, QT prolonging agents - QT prolonging agents]
[L01DB04, aclarubicin, QT prolonging agents - QT prolonging agents]
[P01BA01, chloroquine, QT prolonging agents - QT prolonging agents]
[N05AA01, chlorpromazine, QT prolonging agents - QT prolonging agents]
[N05AF03, chlorprothixene, QT prolonging agents - QT prolonging agents]
[S03AA07, ciprofloxacin, QT prolonging agents - QT prolonging agents]
[N06AB04, citalopram, QT prolonging agents - QT prolonging agents]
[L01EB10, mobocertinib, QT prolonging agents - QT prolonging agents]
[A04AA01, ondansetron, QT prolonging agents - QT prolonging agents]
[S02DA02, cocaine, QT prolonging agents - QT prolonging agents]
[C01BA13, hydroquinidine, QT prolonging agents - QT prolonging agents]
[P01CB01, meglumine antimoniate, QT prolonging agents - QT prolonging agents]
[L01XA03, oxaliplatin, QT prolonging agents - QT prolonging agents]
[A03FA02, cisapride, QT prolonging agents - QT prolonging agents]
[C01BA03, disopyramide, QT prolonging agents - QT prolonging agents]
[A03FA03, domperidone, QT prolonging agents - QT prolonging agents]
[N01AB08, sevoflurane, QT prolonging agents - QT prolonging agents]
[N05AD08, droperidol, QT prolonging agents - QT prolonging agents]
[N05AL02, sultopride, QT prolonging agents - QT prolonging agents]
[G04BD05, terodiline, QT prolonging agents - QT prolonging agents]
[S01AA17, erythromycin, QT prolonging agents - QT prolonging agents]
[C01BD05, ibutilide, QT prolonging agents - QT prolonging agents]
[N05AE03, sertindole, QT prolonging agents - QT prolonging agents]
[R06AX11, astemizole, QT prolonging agents - QT prolonging agents]
[R06AX12, terfenadine, QT prolonging agents - QT prolonging agents]
[C01BC04, flecainide, QT prolonging agents - QT prolonging agents]
[J02AC01, fluconazole, QT prolonging agents - QT prolonging agents]
[C01BD04, dofetilide, QT prolonging agents - QT prolonging agents]
[P01BX01, halofantrine, QT prolonging agents - QT prolonging agents]
[N05AD01, haloperidol, QT prolonging agents - QT prolonging agents]
[P01BA02, hydroxychloroquine, QT prolonging agents - QT prolonging agents]
[H01BA04, terlipressin, QT prolonging agents - QT prolonging agents]
[L01XX35, anagrelide, QT prolonging agents - QT prolonging agents]
[N05AC03, mesoridazine, QT prolonging agents - QT prolonging agents]
[N07BC02, methadone, QT prolonging agents - QT prolonging agents]
[N05AA02, methotrimeprazine, QT prolonging agents - QT prolonging agents]
[C01BD01, amiodarone, QT prolonging agents - QT prolonging agents]
[S01AE05, levofloxacin, QT prolonging agents - QT prolonging agents]
[N05AG02, pimozide, QT prolonging agents - QT prolonging agents]
[J01MA11, grepafloxacin, QT prolonging agents - QT prolonging agents]
[C10AX02, probucol, QT prolonging agents - QT prolonging agents]
[C01BA02, procainamide, QT prolonging agents - QT prolonging agents]
[N01AX10, propofol, QT prolonging agents - QT prolonging agents]
[C01BA01, quinidine, QT prolonging agents - QT prolonging agents]
[J01FA06, roxithromycin, QT prolonging agents - QT prolonging agents]
[C07AA07, sotalol, QT prolonging agents - QT prolonging agents]
